Health care’s biggest annual gathering — the J.P. Morgan Healthcare Conference — begins Monday in San Francisco as the industry grapples with threats from Washington to Silicon Valley.
In excess of 485 organizations from biotech, pharma, insurance, hospital systems and more will give speculator introductions to in excess of 9,000 participants at the Westin St. Francis hotel this year. Significantly additionally counseling organizations and law offices will flood hotel suites and conference rooms near Union Square to host meetings that executives compare to speed dating for investors.
In its 37th year, the four-day meeting has helped shape the plan for both the industry and individual organizations for the year. A few officials share their monetary estimates or achievements speculators can anticipate from drug pipelines. Others touch on themes for the industry, with tax reform being a major focus last year.
Drug costs will probably be a noteworthy point this year. As president-elect two years prior, Donald Trump made his now-infamous remark amid the meeting that drug organizations were “getting away with murder.” Since at that point, he has installed Scott Gottlieb as commissioner of the Food and Drug Administration and Alex Azar as Health and Human Services secretary with directions to bring down drug costs. (Gottlieb is showing his keynote speech Tuesday via teleconference from Washington because of the federal government shutdown.)
Health care’s intersection with technology will likewise likely be a noteworthy theme throughout the week. One name stoking both excitement and fear: Amazon.
The organization’s stressed Wall Street for quite a while. Be that as it may, Amazon’s entrance into the industry is no longer hypothetical with its purchase of online pharmacy PillPack a year ago.
